ERT

Jeffrey S. Litwin, M.D. has been appointed president and chief executive officer of ERT and a member of the board. Dr. Litwin joined the company in 2000 as senior vice president and chief medical officer and was subsequently promoted in December 2005 to executive vice president and chief medical officer.

Dr. Joel Morganroth, who had served as interim president and chief executive officer, said, “After a thorough national search by Heidrick and Struggles, our board selected Dr. Litwin, an internal candidate, as the most qualified person to lead ERT. Jeff brings to ERT knowledge of the clinical research domain that is our core business, and also experience in the adjacent markets of Phase IV safety surveillance and healthcare in which ERT’s assets will be employed. All of our employees look forward to continuing to work with Jeff to enhance ERT’s operational successes and strategy.”

Dr. Litwin oversaw ERT’s global cardiac safety operations for seven years and was instrumental in implementing EXPERT, ERT’s digital operating system. Dr. Litwin also serves on the DIA Annual Meeting planning committee, the Applied Clinical Trials Editorial Board, and the Board of Directors of the Metrics Champion Consortium.

The board also elected Elam M. Hitchner, III to succeed Dr. Morganroth as chairman. Mr. Hitchner has served since April 2010 as the lead independent director of the board.